Contrast-enhanced ultrasound in the therapeutic assessment of diffuse large B-cell lymphoma: A case report
- Authors:
- Published online on: August 16, 2017 https://doi.org/10.3892/ol.2017.6758
- Pages: 4593-4598
-
Copyright: © Du et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Abstract
Contrast-enhanced computed tomography (CECT) has been extensively used in the restaging and assessment of treatment response for diffuse large B‑cell lymphoma (DLBCL). However, CECT does not provide information regarding the specific functionality of lesions. A patient (56 years old, female) was previously admitted to the present institution, with bilateral cervical masses. Following numerous cycles of chemotherapy, a stable disease status was confirmed using CECT. In conjunction with CECT imaging results, contrast‑enhanced ultrasound (CEUS) demonstrated important semi‑functional information regarding blood perfusion, during the revision of treatment assessment. 18F-fluoro‑2-deoxyglucose (FDG)‑positron emission tomography‑computed tomography imaging demonstrated no increase in FDG uptake of the same tumor lesion, consistent with the results of CEUS. CEUS exhibited the potential to present complementary results to CECT, in the therapeutic assessment of DLBCL, which, to the best of our knowledge, has not previously been reported.
